OMGA · Omega Therapeutics
Acquired Company
Omega Therapeutics was acquired by Pioneering Medicines 08-B, Inc. (an affiliate of Flagship Pioneering) in a bankruptcy sale closed on August 8, 2025.
Omega Therapeutics Inc is a pioneering biotechnology company dedicated to developing innovative epigenetic mRNA medicines targeting a wide array of diseases. Utilizing its proprietary Omega Epigenetics Engine, the company is poised to unlock the potential of the epigenome, driving advancements in genetics and personalized medicine. With a promising pipeline of therapeutics spanning multiple developmental stages, Omega Therapeutics stands at the forefront of precision healthcare, strategically addressing some of the most significant unmet medical needs. Its unwavering commitment to scientific excellence and strategic collaborations positions it as a key player in reshaping treatment paradigms for patients globally.
Market Cap
7.895M
52 Wk Range
$0.00 - $0.00
Previous Close
$0.14
Open
$0.14
Volume
N/A
Day Range
$0.14 - $0.14
Enterprise Value
N/A
Cash
30.38M
Avg Qtr Burn
-14.02M
Insider Ownership
1.67%
Institutional Own.
87.75%
Qtr Updated
Sep 30th 2024
